title: Psychopharmacological treatment of psychotic children. A survey.
abstract: Controlled investigations on the psychopharmacological treatment of psychotic children are reviewed. Children with infantile autism might benefit from psychopharmacological medication when they grow older, e.g. above the age of 7 years. Learning might be facilitated when the psychoactive medication is able to inhibit psychotic preoccupations and idiosyncratic reactions. Schizophrenic and manic-depressive psychoses are rarely seen in childhood. A subgroup of the children with infantile autism might develop schizophrenic symptoms. Schizophrenia and manic-depressive psychosis in children are treated as in adults. Special caution must be paid to the toxic effects of imipramine.
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001321:Autistic Disorder / Q000188:drug therapy; D001714:Bipolar Disorder / Q000188:drug therapy; D002648:Child; D006801:Humans; D007099:Imipramine / Q000009:adverse effects / Q000627:therapeutic use; D010640:Phenothiazines; D011618:Psychotic Disorders / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012561:Schizophrenia, Childhood / Q000188:drug therapy
chemical_list: D014150:Antipsychotic Agents; D010640:Phenothiazines; D011619:Psychotropic Drugs; D007099:Imipramine